Gland Pharma Limited (BOM:543245)
2,200.95
+3.80 (0.17%)
At close: Jun 18, 2026
Gland Pharma Employees
Gland Pharma had 4,351 employees as of March 31, 2025. The number of employees increased by 134 or 3.18% compared to the previous year.
Employees
4,351
Change (1Y)
134
Growth (1Y)
3.18%
Revenue / Employee
14.78M INR
Profits / Employee
2.36M INR
Market Cap
362.30B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,351 | 134 | 3.18% |
| Mar 31, 2024 | 4,217 | -368 | -8.03% |
| Mar 31, 2023 | 4,585 | -54 | -1.16% |
| Mar 31, 2022 | 4,639 | 678 | 17.12% |
| Mar 31, 2021 | 3,961 | 170 | 4.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Lupin | 24,006 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 4,500 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
Gland Pharma News
- 5 days ago - Gland Pharma announces resignation of independent director Satyanarayana Murthy Chavali - Business Upturn
- 12 days ago - Divi's Labs jumps 3.33%, Piramal Pharma 3.77%, Gland Pharma 2.68% after Pentagon blacklists WuXi AppTec - Business Upturn
- 19 days ago - Gland Pharma increases share capital with allotment of 2,03,259 equity shares - Business Upturn
- 4 weeks ago - Top gainers today: gland pharma at ₹2,156.60 up 15.43%, coforge at ₹1,348.10 up 5.15%, persistent systems at ₹4,944.10 up 5.15% - Business Upturn
- 4 weeks ago - Top gainers in morning trade: gland pharma at ₹2,127 up 13.85%, shipping corporation of India at ₹348.50 up 5.16%, carborundum universal at ₹1,139 up 3.32% - Business Upturn
- 4 weeks ago - Why Gland Pharma shares are up over 12% today? Explained - Business Upturn
- 5 weeks ago - Gland Pharma Transcript: Q4 25/26 - Transcripts
- 5 weeks ago - Gland Pharma Quarterly report: Q4 2026 - Filings